GlassScriptPhysician profile
Angela Davis
NPI 1740523919
$5,045.95
in general payments reported to CMS, 2019-2025
18 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $344 · 2022: $972 · 2023: $825 · 2024: $1,309 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,703 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,703.13 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,493.15 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $824.85 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $629.07 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $507.19 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $448.78 | 2021-2025 | Aristada, Lybalvi |
| Vanda Pharmaceuticals INC. | $286.97 | 2023-2025 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $196.97 | 2022-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $160.68 | 2022-2025 | Austedo Xr, Austedo, Austedo Xr |
| Corium, LLC | $120.71 | 2024-2025 | Azstarys |
| Lundbeck LLC | $108.97 | 2021-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $76.04 | 2024-2025 | Cobenfy |
| Integra Lifesciences Corporation | $58.96 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bausch Health US, LLC | $33.29 | 2023-2024 | Wellbutrin, Aplenzin |
| Ironshore Pharmaceuticals INC. | $33.04 | 2024 | |
| Almatica Pharma LLC | $17.90 | 2025 | Loreev Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $17.45 | 2024 | Xtampza |
| Tempus Ai, INC | $17.42 | 2024 | |
| Depuy Synthes Sales INC. | $14.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.